ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...

Luhn Algorithm: Verify Credit Card Numbers & Ensure Accuracy

Discover how the Luhn Algorithm verifies credit card accuracy, supports secure transactions, and helps prevent errors in inputting Social Security numbers.
IEEE

Improving Programming Learning in Engineering Students Through Discovery Learning

Abstract: Programming is basic to all engineering studies and a complicated subject for many first-year students. Many of the problems stem from the difficulty students have in finding the solution ...